SCHEMBL3185201

SCHEMBL3185201

O=C(O)CC1CCC(F)(F)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRB2 P47870 2/20 0.39
SLC6A12 P48065 2/20 0.39
SLC6A11 P48066 2/20 0.39
SLC6A13 Q9NSD5 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRR1 P24046 1/20 0.39
GABRA4 P48169 1/20 0.39
APLNR P35414 1/20 0.38
FFAR4 Q5NUL3 8/20 0.36
FFAR1 O14842 1/20 0.36
GRM2 Q14416 2/20 0.35
GRM5 P41594 1/20 0.35
GRM1 Q13255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
S1PR4 O95977 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29224201 1.00 SLC6A1 (0.39) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL30817070 0.88 SLC6A1 (0.37) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL940485 0.87 SLC6A1 (0.42) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL15114485 0.82 APLNR (0.50) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL27929751 0.82 APLNR (0.37) APLNR
SCHEMBL28985024 0.80 FFAR4 (0.38) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL8040596 0.78 APLNR (0.41) APLNR
SCHEMBL2487994 0.77 BRD4 (0.39) APLNRMAPT
SCHEMBL28158468 0.77 APLNR (0.39) APLNR
SCHEMBL14592382 0.75 SLC6A1 (0.39) SLC6A1GABRA5GABRB2SLC6A12SLC6A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072539-A1 AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF PLIANT THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed
CN-118119613-A Benzimidazoles as IL-17 modulators 詹森药业有限公司 2024-05-31 CN disclosed
CN-108473518-B Bisphosphonic acid compounds 株式会社富士药品 2021-07-06 CN disclosed
US-10689408-B2 Bisphosphonic acid compound FUJIYAKUHIN CO., LTD. (JP) 2020-06-23 US disclosed
US-20190002482-A1 NOVEL BISPHOSPHONIC ACID COMPOUND FUJIYAKUHIN CO., LTD. (JP) 2019-01-03 US disclosed
EP-3409679-A1 NOVEL BISPHOSPHONIC ACID COMPOUND Fuji Yakuhin Co., Ltd. (JP) 2018-12-05 EP disclosed
CN-108473518-A New double phosphinic acid compounds 株式会社富士药品 2018-08-31 CN disclosed
CN-103796989-B Branched 3-phenylpropionic acid derivatives and uses thereof 拜耳知识产权有限责任公司 2017-03-01 CN disclosed
CN-103796989-A Branched 3-phenylpropionic acid derivatives and uses thereof BAYER IP GMBH 2014-05-14 CN disclosed
CN-103492361-A Substituted 1-benzylcycloalkylcarboxlic acids and use thereof BAYER IP GMBH 2014-01-01 CN disclosed
US-7662402-B2 contains fluoroalkyl group; insecticides, miticides, nematocides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 US disclosed
US-20070112068-A1 Nitrile compound and its use in pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112068-A1 Nitrile compound and its use in pest control C5, C9, C1S SLC6A1 2983/4885GABRA5 4022/4885GABRB2 3619/4885
US-10689408-B2 Bisphosphonic acid compound SOST, PTH1R, BMP2 SLC6A1 195/4885GABRA5 204/4885GABRB2 277/4885
US-20190002482-A1 NOVEL BISPHOSPHONIC ACID COMPOUND SOST, PTH1R, BMP2 SLC6A1 204/4885GABRA5 226/4885GABRB2 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.